December 2, 2019December 2, 2019

Abivax’s Phase 2b Trial Testing ABX464 for Ulcerative Colitis Cleared to Add French Sites

News

France’s National Agency for the Safety of Medicine and Health Products (ANSM) has cleared the inclusion of French study sites for Abivax‘s new Phase 2b clinical trial, intended to evaluate ... Read more

June 17, 2019June 17, 2019

Nine-Month Results Show Continuing Efficacy of Abivax’s ABX464 in Extension Trial

News

Treatment with Abivax‘s ABX464 showed continuing effectiveness in ulcerative colitis patients, according to nine-month data of a maintenance clinical trial. The company is now recruiting people with moderate-to-severe ulcerative colitis ... Read more